SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Macro International informs about outcome of board meeting

10 Nov 2021 Evaluate

Pursuant to the Regulation 33 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulation, 2015 (Listing Regulations), Macro International has informed that the Board of Directors at their meeting held on Wednesday, 10th November, 2021 at 1.30 pm have considered and approved, the Unaudited Financial Results of the company for the quarter and the half Year ended on September 30th, 2021 along with the limited review report of the auditors thereon. A copy of the results along with Auditor's Report is enclosed.

The above information is a part of company’s filings submitted to BSE.

Astal Laboratories Share Price

67.30 0.04 (0.06%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×